Loading chat...
HI HB2630
Bill
Status
1/24/2024
Primary Sponsor
Della au Belatti
Click for details
AI Summary
HB 2630 Summary
-
Authorizes therapeutic use of psilocybin for qualifying patients with debilitating mental health conditions including depression, anxiety, PTSD, addiction, and eating disorders, with a licensed medical professional's written certification.
-
Limits psilocybin administration to a maximum of 5 grams per session and requires patients to complete preparation, administration, and integration sessions with a trained facilitator.
-
Establishes facilitator eligibility requirements including age 21+, high school diploma, state residency, and completion of a department-approved psychedelic integration training program.
-
Provides legal protections for qualifying patients, primary caregivers, and licensed medical professionals who comply with the law, allowing therapeutic use as an affirmative defense to drug possession charges.
-
Prohibits therapeutic use in schools, workplaces, public spaces, vehicles, and other public areas; creates penalties for fraudulent misrepresentation or non-compliant medical certifications.
Legislative Description
Relating To Mental Health Treatment.
Authorization
Last Action
Report adopted. referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; Representative(s) Alcos, Garcia, Kila, Kitagawa, Lamosao, Matayoshi, Matsumoto, Pierick, Ward voting no (9) and Representative(s) Aiu, Garrett, Perruso, Takayama, Todd excused (5).
2/16/2024